NYC Dept. Health / Mental Hygiene Screening for Depression
NYC Dept. Health / Mental Hygiene Screening for Depression
– designed to ensure the entire US population ranks as depressed
Similar Posts
Will NIH Ban on Consulting Deals with Drug Firms Set an Ethical Example? LAT / NYT
Will NIH Ban on Consulting Deals with Drug Firms Set an Ethical Example? LAT / NYT Wed, 2 Feb 2005 The Los Angeles Times, whose investigative reports about conflicts of interest at the National Institutes of Health, shook the foundations of NIH by prying open the vaults that contained secret…
InfoMail for March 4, 2002
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav March 4, 2002 Mind Drugs May Hinder Recovery FYI Robert Whitaker, author of Mad in America, adocumented critique of the mistreatment of schizophrenic patients in the U.S.,has…
Accutane Suicide Controversy–small study finds depression reduced
Accutane Suicide Controversy–small study finds depression reduced Tue, 17 May 2005 Accutane–a drug prescribed for acne has been linked to suicide and birth defects–it carries bold warnings about birth defects. A small non-blinded study finding is being touted by Hoffman-La Roche, manufacturer of Accutane. The study found the drug did…
CATIE study results Contradict Current Clinical Practice & Treatment Guidelines
Newly published results (phase II) from the CATIE schizophrenia treatment efficacy study sponsored by the National Institute of Mental Health comparing the most commonly used second generation drug treatments for schizophrenia and depression, is highly disturbing.
Reply to the ACNP’s Report on SSRI and Suicidal Behavior in Children – Leo
Reply to the American College of Neuropharmacology’s Report on SSRI and Suicidal Behavior in Children Jonathan Leo, Ph.D. Introduction The American College of Neuropsychopharmacology (ACNP) recently released an Executive Summary from its Task Force on SSRIs and Suicidal Behavior. The task force concluded that "taking Selective Serotonin Reuptake Inhibitors (SSRIs)…
FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers – NYT
FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers – NYT Thu, 17 Feb 200 A three day public advisory panel hearing which is overflowing with attendees from around the world, is an investigation of the conduct of pharmaceutical company giants and the FDA. The hearing began…